We Are the Leading Preclinical CRO Company for Stroke
Ace Therapeutics is an innovative CRO company focusing in early drug discovery services from target validation to preclinical candidate identification and efficacy evaluation, with strong capabilities and technologies in the stroke field. Ace Therapeutics provides highly professional communication and flexible collaboration model to accelerate the drug discovery process in stroke better and faster.
Ace Therapeutics has multiple technology platforms related to biology and pharmacology to support a variety of drug discovery purposes for different types of stroke needs. Today, Ace Therapeutics can coordinate global resources and apply a multidisciplinary perspective to address the unique challenges of your stroke program. We focus on timeliness and accuracy at every stage of development.
